23 Apr 2020

Explores drug supply-oriented policies and interventions, the future challenges of drug policy, and how to improve indicators such that they appropriately incorporate harms.

Read the full article here.
This content was originally published by Rand Organization. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Rand Organization

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.